Crosstalk between repair pathways elicits double-strand breaks in alkylated DNA and implications for the action of temozolomide
Temozolomide (TMZ), a DNA methylating agent, is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O6-methylguanine (O6mG) adducts. Current models propose that during DNA replication, thymine is i...
Main Authors: | Robert P Fuchs, Asako Isogawa, Joao A Paulo, Kazumitsu Onizuka, Tatsuro Takahashi, Ravindra Amunugama, Julien P Duxin, Shingo Fujii |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/69544 |
Similar Items
-
The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
by: Jiahui Zhu, et al.
Published: (2022-11-01) -
New Discoveries on Protein Recruitment and Regulation during the Early Stages of the DNA Damage Response Pathways
by: Kelly L. Waters, et al.
Published: (2024-01-01) -
DNA damage repair in ovarian cancer: unlocking the heterogeneity
by: Mary Ellen Gee, et al.
Published: (2018-06-01) -
7.346 DNA Wars: How the Cell Strikes Back to Avoid Disease after Attacks on DNA, Fall 2013
by: Jordan, Jennifer, et al.
Published: (2023) -
Features of DNA Repair in the Early Stages of Mammalian Embryonic Development
by: Evgenia V. Khokhlova, et al.
Published: (2020-09-01)